BN83495
Sponsors
Ipsen
Conditions
Breast CancerEndometrial Cancer
Phase 2
The Study of Oral Steroid Sulphatase Inhibitor BN83495 Versus Megestrol Acetate (MA) in Women With Advanced or Recurrent Endometrial Cancer
CompletedNCT00910091
Start: 2009-08-31End: 2013-07-31Updated: 2019-01-30
Exploratory Study to Assess the Short Term Intratumoural and Peripheral Effects of BN83495 in Postmenopausal Women With Newly Diagnosed Breast Cancer
TerminatedNCT01230970
Start: 2011-05-31End: 2011-05-31Updated: 2019-01-07
Study of BN83495 in Post-menopausal Women With Endometrial Cancer Post-chemotherapy
TerminatedNCT01251354
Start: 2010-11-30End: 2011-07-31Updated: 2019-01-14